Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin-Dembinsky

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Expert Review of Clinical Immunology|May 6, 2010
Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meetingDimitrios Karussis, Adi Vaknin-Dembinsky
The Israel Medical Association Journal : IMAJ|June 9, 2012
Pediatric demyelinating diseases: multiple sclerosis or not?Adi Vaknin-Dembinsky, Dimitrios Karussis
Current Treatment Options in Neurology|March 12, 2013
Central nervous system vasculitisMarc Gotkine, Adi Vaknin-Dembinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2017
Response to letter from Dr Hongliang Zhang entitled 'B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis'Adi Vaknin-Dembinsky, Dimitrios Karussis
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 9, 2012
Neurologic manifestations of systemic immunopathological diseasesMarc Gotkine, Adi Vaknin-Dembinsky
Journal of the Neurological Sciences|May 25, 2007
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapyAdi Vaknin-Dembinsky, Howard L Weiner
Multiple Sclerosis and Related Disorders|April 17, 2019
Corrigendum to "Foxp3+ regulatory T cells expression in Neuromyelitis optica spectrum disorders" [Multiple Sclerosis and Related Disorders 30 (2019) 114-118]Livnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Multiple Sclerosis and Related Disorders|February 17, 2019
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disordersLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Current Stem Cell Research & Therapy|October 20, 2010
Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotectionIbrahim Kassis, Adi Vaknin-Dembinsky, Dimitrios Karussis
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Expert Review of Clinical Immunology|May 6, 2010
Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meetingDimitrios Karussis, Adi Vaknin-Dembinsky
The Israel Medical Association Journal : IMAJ|June 9, 2012
Pediatric demyelinating diseases: multiple sclerosis or not?Adi Vaknin-Dembinsky, Dimitrios Karussis
Current Treatment Options in Neurology|March 12, 2013
Central nervous system vasculitisMarc Gotkine, Adi Vaknin-Dembinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2017
Response to letter from Dr Hongliang Zhang entitled 'B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis'Adi Vaknin-Dembinsky, Dimitrios Karussis
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 9, 2012
Neurologic manifestations of systemic immunopathological diseasesMarc Gotkine, Adi Vaknin-Dembinsky
Journal of the Neurological Sciences|May 25, 2007
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapyAdi Vaknin-Dembinsky, Howard L Weiner
Multiple Sclerosis and Related Disorders|April 17, 2019
Corrigendum to "Foxp3+ regulatory T cells expression in Neuromyelitis optica spectrum disorders" [Multiple Sclerosis and Related Disorders 30 (2019) 114-118]Livnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Multiple Sclerosis and Related Disorders|February 17, 2019
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disordersLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Current Stem Cell Research & Therapy|October 20, 2010
Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotectionIbrahim Kassis, Adi Vaknin-Dembinsky, Dimitrios Karussis
Pageof 10